Health care planning

In plain words: Health: treatment options and follow-up

Designed 2 min read 3 glossary terms 2 connected pages
The short version written for the Snayu team

How Health compares treatment options for human review, binds an exact approval, and records follow-up of what actually happened.

Why read it: Read when building care proposals, approval screens or adherence tracking for health.
  1. 1A proposal is not a prescription; approval is not administration.
  2. 2Approving one option covers no alternatives, refills or purchases.
  3. 3Follow-up records confirmed events only; reminders or silence prove nothing.

Words on this page, decoded click one for its card

The original text Underlined words open their plain-English card.

A reviewed case can lead to several treatment options, each resting on facts and assumptions that the person and qualified professional need to see. health.plan_care@1 develops those options from externally established facts or explicitly declared diagnostic assumptions. health.follow_up@1 later records what the person or qualified professional says happened. Keep each step distinct: a proposal is not a prescription, a verdict is not administration, and a plan is not evidence of adherence or benefit.

Compare care options

CareProposal@1 binds the person, profile and case revisions, clinical basis and unresolved assumptions, goal, option, evidence scope, expected benefit, material risks, contraindications and interactions checked, unknown interactions, alternatives including no action, required clinician or prescriber, monitoring, escalation and stop conditions, duration, review date, and expiry. Unsupported dose conversion, incomplete medication or allergy review, or missing authority blocks the affected option.

The CompositionApp may explain externally issued instructions and prepare questions for a clinician. It cannot issue or renew a prescription, alter a dose, recommend stopping prescribed medication, claim an interaction check is complete beyond its admitted sources, or convert patient consent into professional authorization. Low-risk self-care, clinician-supervised treatment, medication, procedure, rehabilitation, and watchful waiting remain distinct effect classes with distinct policy.

One exact human verdict

When an option is eligible for HitLApproval Step, its call binds the exact person and case; profile and evidence revisions; diagnostic basis; intervention, medicine or device identity; dose, route, frequency, duration and timing where applicable; prerequisites, monitoring and stop conditions; actor and required qualification; disclosures and destination; cost ceiling; policy revision; and expiry. Any clinically relevant change creates a new call. Approval of one option does not approve its alternatives, refills, substitutions, later cycles, purchases, sharing, or administration.

The person making this verdict needs to see the choice and its consequences together. The AltarControl Panel should show evidence for and against the option, unresolved fields, likely and severe risks, alternatives, reversibility, the required professional role, and what approval can and cannot cause. Denial closes that proposal without effect; revision returns to planning. Approval authorizes only an eligible next effect, which its owner must recheck. It does not attest safety or outcome.

Prescription, test ordering, dispensing, booking, payment, device control, and treatment delivery remain external effects until separately governed owners are accepted and integrated. A human-entered confirmation or attributable external receipt may record one of them. Missing acknowledgement remains unknown and must be reconciled before retry.

Follow up without inventing success

HealthFollowUp@1 can record a confirmed start, dose or session, skip, deviation, symptom change, measurement, adverse event, patient reflection, clinician assessment, stop, or unknown outcome, each with source, time, uncertainty, and linked proposal. A reminder, purchase, dispensation, schedule, silence, or model inference proves none of these.

Adverse events and red flags stop ordinary progression and return the applicable professional or emergency handoff. Follow-up may propose a review; it cannot automatically escalate a dose, continue an expired plan, punish non-adherence, or suppress contradictory testimony. Restart recovers exact receipts and pending unknown effects without duplicating a treatment event or reusing an obsolete verdict.


Health · Consultation